Facebook
Messenger
Twitter
LinkedIn
Email
Print
Monoclonal Antibodies: Update on COVID-19 Experimental Therapy
Share this:
Current experimental treatments for COVID-19 focus on two targets: the virus or the immune system. On the immune system side, the number of experimental treatments is growing. The vast majority are called monoclonal antibodies.
This type of drug is not new, and many are currently approved to treat conditions such as cancer or rheumatoid arthritis. But some are being developed from scratch to boost the initial immune response for patients who are at risk of severe COVID-19 disease.
These experimental drugs may provide patients with a way to get ahead of the virus and help manage the strain on hospital intensive care services. But what are monoclonal antibodies?
Read more about this crucial tool in the fight against COVID-19 in Discovery's Edge, Mayo Clinic's research magazine offering insight into the process and progress of medical science at the world's largest group medical practice.
Make a gift now to help transform the future of health care today.
Brian Hardaway, M.D., says what got him into transplant medicine was the long relationships physicians developed with their patients. "You're following patients for years. Transplant medicine is like planting a seed and watching an oak tree grow." That's something Dr. Hardaway understands as a physician, but also as a patient. In addition to caring for people before and after transplants, he's been both an organ donor and a recipient. He knows firsthand that good things grow when transplants take root.
Yonghun Kim grew up in North Carolina, half a world away from his grandfather in South Korea. They didn’t see each other often but built a special relationship through cheering on a hometown baseball team and taking peaceful walks on local trails together on Yonghun’s rare visits to South Korea. When his grandfather was diagnosed with terminal gallbladder cancer, Yonghun felt helpless. Yonghun decided to change that feeling following the death of his grandfather by becoming a physician.
John Berry’s family made the world accessible at one’s fingertips — his grandfather launched a telephone directory publishing business in Dayton, Ohio, that brought the yellow pages to people all over the globe. And when the Berry family needed answers for a medical need, they knew who to call. For three generations, Mayo Clinic has provided serious and complex care to the Berrys.